Home › Companies › Quest Diagnostics Incorporated › 2025-2026
Compiled from SEC Form N-PX filings and Quest Diagnostics Incorporated’s Form 8-K (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore Quest Diagnostics Incorporated in the interactive database Compare manager voting policies
These tallies are Quest Diagnostics Incorporated’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Robert B. Carter | 93,821,069 | 205,166 | 173,510 | -- | 9,135,906 | Majority: yes |
| Elect Director: James E. Davis | 88,799,800 | 5,237,756 | 162,189 | -- | 9,135,906 | Majority: yes |
| Elect Director: Luis A. Diaz, Jr., M.D. | 93,909,369 | 110,114 | 180,262 | -- | 9,135,906 | Majority: yes |
| Elect Director: Tracey C. Doi | 93,649,938 | 393,268 | 156,539 | -- | 9,135,906 | Majority: yes |
| Elect Director: Vicky B. Gregg | 83,814,387 | 10,232,574 | 152,784 | -- | 9,135,906 | Majority: yes |
| Elect Director: Wright L. Lassiter, III | 93,802,306 | 223,154 | 174,285 | -- | 9,135,906 | Majority: yes |
| Elect Director: Timothy L. Main | 88,302,767 | 5,614,920 | 282,058 | -- | 9,135,906 | Majority: yes |
| Elect Director: Denise M. Morrison | 89,808,461 | 4,176,407 | 214,877 | -- | 9,135,906 | Majority: yes |
| Elect Director: Gary M. Pfeiffer | 86,302,153 | 7,716,970 | 180,622 | -- | 9,135,906 | Majority: yes |
| Elect Director: Timothy M. Ring | 81,917,543 | 11,994,424 | 287,778 | -- | 9,135,906 | Majority: yes |
| Elect Director: Timothy C. Wentworth | 93,427,490 | 597,095 | 175,160 | -- | 9,135,906 | Majority: yes |
| The advisory resolution to approve the executive officer compensation disclosed in the Company's 2026 Proxy Statement was approved by the following votes: | 86,869,738 | 7,152,448 | 177,559 | -- | 9,135,906 | Majority: yes |
| The ratification of the appointment of PricewaterhouseCoopers as the Company's independent registered public accounting firm for 2026 was approved by the following votes: | 97,340,034 | 5,809,995 | 185,622 | -- | -- | Majority: yes |
| The stockholder proposal regarding an independent board chairman was not approved by the following votes: | 23,999,636 | 69,792,819 | 407,290 | -- | 9,135,906 | Majority: no |
Source: Quest Diagnostics Incorporated, Form 8-K — read the filing on EDGAR.
Each item below shows how the 926 asset managers that disclosed a Quest Diagnostics Incorporated vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Quest Diagnostics Incorporated’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held 2026-05-20.
Combines 21 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
Quest Diagnostics Incorporated’s own tally for this item (“The advisory resolution to approve the executive officer compensation disclosed in the Company's 2026 Proxy Statement was approved by the following votes:”): 86,869,738 for, 7,152,448 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 110,696,429 outstanding shares: 78% for, 6% against (85% of the company cast a for/against vote).
The 891 asset managers below cast 95% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 14,442,089 | 117 | 2 | 0 | For |
| T. Rowe Price | 9,783,341 | 80,109 | 0 | 0 | For |
| BlackRock | 7,351,606 | 51,309 | 0 | 0 | For |
| Fidelity | 4,273,420 | 0 | 0 | 0 | For |
| Boston Partners | 3,483,429 | 0 | 0 | 0 | For |
| State Street | 3,342,353 | 52,379 | 0 | 0 | For |
| Victory Capital | 3,094,105 | 0 | 0 | 0 | For |
| Invesco | 3,078,752 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 3,076,826 | 0 | 0 | 0 | For |
| JPMorgan | 2,661,707 | 0 | 0 | 0 | For |
| John Hancock | 2,305,359 | 0 | 0 | 0 | For |
| EdgePoint Investment Group Inc. | 2,241,487 | 0 | 0 | 0 | For |
| Grantham, Mayo, Van Otterloo & Co. LLC | 1,644,108 | 0 | 0 | 0 | For |
| DAVIS SELECTED ADVISERS | 1,516,804 | 0 | 0 | 0 | For |
| Charles Schwab | 1,497,185 | 0 | 0 | 0 | For |
| WELLS FARGO CLEARING SERVICES, LLC | 1,441,295 | 0 | 0 | 0 | For |
| American Century | 1,397,680 | 0 | 0 | 0 | For |
| Dimensional | 1,361,187 | 0 | 0 | 0 | For |
| Northern Trust | 947,728 | 12,234 | 0 | 0 | For |
| Goldman Sachs | 893,834 | 27 | 0 | 0 | For |
| PGGM Investments | 0 | 675,013 | 0 | 0 | Against |
| AllianceBernstein | 671,832 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 598,472 | 0 | 0 | 0 | For |
| GMO | 568,962 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 524,311 | 0 | 0 | 0 | For |
Showing the 25 largest of 891 asset managers. See all 891 in the interactive database.
Meeting held 2026-05-20.
Combines 7 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Denise M. Morrison”): 89,808,461 for, 4,176,407 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 110,696,429 outstanding shares: 81% for, 4% against (85% of the company cast a for/against vote).
The 172 asset managers below cast 99.9% of the shares they voted on this item FOR (42,471,469 for, 26,945 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,286,610 | 74 | 4 | 0 | For |
| BlackRock | 3,527,385 | 0 | 0 | 0 | For |
| Fidelity | 3,397,386 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,298,943 | 0 | 0 | 0 | For |
| JPMorgan | 2,658,066 | 0 | 0 | 0 | For |
| John Hancock | 2,247,454 | 0 | 0 | 0 | For |
| Invesco | 1,458,667 | 0 | 0 | 0 | For |
| Victory Capital | 1,337,197 | 0 | 0 | 0 | For |
| State Street | 1,254,570 | 0 | 0 | 0 | For |
| Dimensional | 935,911 | 0 | 0 | 0 | For |
| Charles Schwab | 738,419 | 0 | 0 | 0 | For |
| GMO | 568,962 | 0 | 0 | 0 | For |
| American Century | 567,125 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 429,772 | 0 | 0 | 0 | For |
| TIAA | 377,914 | 0 | 0 | 0 | For |
| DAVIS NEW YORK VENTURE FUND INC | 364,350 | 0 | 0 | 0 | For |
| Principal | 330,378 | 0 | 0 | 0 | For |
| First Trust | 316,610 | 0 | 0 | 0 | For |
| DAVIS SERIES INC | 276,843 | 0 | 0 | 0 | For |
| Jackson National | 254,082 | 0 | 0 | 0 | For |
| Goldman Sachs | 207,232 | 0 | 0 | 0 | For |
| FMI FUNDS INC | 190,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 185,672 | 0 | 0 | 0 | For |
| GMO ETF Trust | 176,930 | 0 | 0 | 0 | For |
Showing the 25 largest of 172 asset managers. See all 172 in the interactive database.
Meeting held 2026-05-20.
Combines 7 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Gary M. Pfeiffer”): 86,302,153 for, 7,716,970 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 110,696,429 outstanding shares: 78% for, 7% against (85% of the company cast a for/against vote).
The 172 asset managers below cast 99.4% of the shares they voted on this item FOR (42,255,608 for, 242,807 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,269,276 | 17,409 | 2 | 0 | For |
| BlackRock | 3,527,009 | 376 | 0 | 0 | For |
| Fidelity | 3,397,386 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,298,943 | 0 | 0 | 0 | For |
| JPMorgan | 2,658,066 | 0 | 0 | 0 | For |
| John Hancock | 2,247,454 | 0 | 0 | 0 | For |
| Invesco | 1,458,667 | 0 | 0 | 0 | For |
| Victory Capital | 1,337,197 | 0 | 0 | 0 | For |
| State Street | 1,254,554 | 16 | 0 | 0 | For |
| Dimensional | 935,911 | 0 | 0 | 0 | For |
| Charles Schwab | 738,419 | 0 | 0 | 0 | For |
| GMO | 568,962 | 0 | 0 | 0 | For |
| American Century | 567,125 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 429,772 | 0 | 0 | 0 | For |
| TIAA | 377,914 | 0 | 0 | 0 | For |
| DAVIS NEW YORK VENTURE FUND INC | 364,350 | 0 | 0 | 0 | For |
| Principal | 330,378 | 0 | 0 | 0 | For |
| First Trust | 316,610 | 0 | 0 | 0 | For |
| DAVIS SERIES INC | 276,843 | 0 | 0 | 0 | For |
| Jackson National | 254,082 | 0 | 0 | 0 | For |
| Goldman Sachs | 207,232 | 0 | 0 | 0 | For |
| FMI FUNDS INC | 190,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 185,672 | 0 | 0 | 0 | For |
| GMO ETF Trust | 176,930 | 0 | 0 | 0 | For |
Showing the 25 largest of 172 asset managers. See all 172 in the interactive database.
Meeting held 2026-05-20.
Combines 8 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: James E. Davis”): 88,799,800 for, 5,237,756 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 110,696,429 outstanding shares: 80% for, 5% against (85% of the company cast a for/against vote).
The 172 asset managers below cast 99.6% of the shares they voted on this item FOR (42,339,937 for, 158,476 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,286,597 | 86 | 1 | 0 | For |
| BlackRock | 3,527,385 | 0 | 0 | 0 | For |
| Fidelity | 3,397,386 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,298,943 | 0 | 0 | 0 | For |
| JPMorgan | 2,658,066 | 0 | 0 | 0 | For |
| John Hancock | 2,162,381 | 85,073 | 0 | 0 | For |
| Invesco | 1,458,667 | 0 | 0 | 0 | For |
| Victory Capital | 1,337,197 | 0 | 0 | 0 | For |
| State Street | 1,254,560 | 10 | 0 | 0 | For |
| Dimensional | 931,122 | 4,789 | 0 | 0 | For |
| Charles Schwab | 738,419 | 0 | 0 | 0 | For |
| GMO | 568,962 | 0 | 0 | 0 | For |
| American Century | 567,125 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 429,772 | 0 | 0 | 0 | For |
| TIAA | 377,914 | 0 | 0 | 0 | For |
| DAVIS NEW YORK VENTURE FUND INC | 364,350 | 0 | 0 | 0 | For |
| Principal | 330,378 | 0 | 0 | 0 | For |
| First Trust | 316,610 | 0 | 0 | 0 | For |
| DAVIS SERIES INC | 276,843 | 0 | 0 | 0 | For |
| Jackson National | 254,082 | 0 | 0 | 0 | For |
| Goldman Sachs | 207,232 | 0 | 0 | 0 | For |
| FMI FUNDS INC | 190,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 185,672 | 0 | 0 | 0 | For |
| GMO ETF Trust | 176,930 | 0 | 0 | 0 | For |
Showing the 25 largest of 172 asset managers. See all 172 in the interactive database.
Meeting held 2026-05-20.
Combines 7 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Timothy L. Main”): 88,302,767 for, 5,614,920 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 110,696,429 outstanding shares: 80% for, 5% against (85% of the company cast a for/against vote).
The 172 asset managers below cast 99.8% of the shares they voted on this item FOR (42,356,883 for, 72,656 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,286,579 | 103 | 5 | 0 | For |
| BlackRock | 3,527,385 | 0 | 0 | 0 | For |
| Fidelity | 3,397,386 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,298,943 | 0 | 0 | 0 | For |
| JPMorgan | 2,658,066 | 0 | 0 | 0 | For |
| John Hancock | 2,247,454 | 0 | 0 | 0 | For |
| Invesco | 1,458,667 | 0 | 0 | 0 | For |
| Victory Capital | 1,337,197 | 0 | 0 | 0 | For |
| State Street | 1,254,554 | 16 | 0 | 0 | For |
| Dimensional | 935,911 | 0 | 0 | 0 | For |
| Charles Schwab | 738,419 | 0 | 0 | 0 | For |
| GMO | 568,962 | 0 | 0 | 0 | For |
| American Century | 567,125 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 429,772 | 0 | 0 | 0 | For |
| TIAA | 377,914 | 0 | 0 | 0 | For |
| DAVIS NEW YORK VENTURE FUND INC | 364,350 | 0 | 0 | 0 | For |
| Principal | 330,378 | 0 | 0 | 0 | For |
| First Trust | 316,610 | 0 | 0 | 0 | For |
| DAVIS SERIES INC | 276,843 | 0 | 0 | 0 | For |
| Jackson National | 254,082 | 0 | 0 | 0 | For |
| Goldman Sachs | 207,232 | 0 | 0 | 0 | For |
| FMI FUNDS INC | 190,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 185,672 | 0 | 0 | 0 | For |
| GMO ETF Trust | 176,930 | 0 | 0 | 0 | For |
Showing the 25 largest of 172 asset managers. See all 172 in the interactive database.
Meeting held 2026-05-20.
Combines 7 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Timothy M. Ring”): 81,917,543 for, 11,994,424 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 110,696,429 outstanding shares: 74% for, 11% against (85% of the company cast a for/against vote).
The 172 asset managers below cast 99% of the shares they voted on this item FOR (41,988,058 for, 510,355 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,269,221 | 17,462 | 5 | 0 | For |
| BlackRock | 3,526,711 | 674 | 0 | 0 | For |
| Fidelity | 3,397,386 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,298,943 | 0 | 0 | 0 | For |
| JPMorgan | 2,658,066 | 0 | 0 | 0 | For |
| John Hancock | 2,247,454 | 0 | 0 | 0 | For |
| Invesco | 1,458,667 | 0 | 0 | 0 | For |
| Victory Capital | 1,337,197 | 0 | 0 | 0 | For |
| State Street | 1,254,554 | 16 | 0 | 0 | For |
| Dimensional | 935,911 | 0 | 0 | 0 | For |
| Charles Schwab | 738,175 | 244 | 0 | 0 | For |
| GMO | 568,962 | 0 | 0 | 0 | For |
| American Century | 567,125 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 429,772 | 0 | 0 | 0 | For |
| TIAA | 377,914 | 0 | 0 | 0 | For |
| DAVIS NEW YORK VENTURE FUND INC | 364,350 | 0 | 0 | 0 | For |
| Principal | 330,378 | 0 | 0 | 0 | For |
| First Trust | 316,610 | 0 | 0 | 0 | For |
| DAVIS SERIES INC | 276,843 | 0 | 0 | 0 | For |
| Jackson National | 254,082 | 0 | 0 | 0 | For |
| Goldman Sachs | 207,232 | 0 | 0 | 0 | For |
| FMI FUNDS INC | 190,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 185,672 | 0 | 0 | 0 | For |
| GMO ETF Trust | 176,930 | 0 | 0 | 0 | For |
Showing the 25 largest of 172 asset managers. See all 172 in the interactive database.
Meeting held 2026-05-20.
Combines 7 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Tracey C. Doi”): 93,649,938 for, 393,268 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 110,696,429 outstanding shares: 85% for, 0.4% against (85% of the company cast a for/against vote).
The 172 asset managers below cast 99.9% of the shares they voted on this item FOR (42,495,528 for, 2,886 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,286,679 | 5 | 1 | 0 | For |
| BlackRock | 3,527,385 | 0 | 0 | 0 | For |
| Fidelity | 3,397,386 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,298,943 | 0 | 0 | 0 | For |
| JPMorgan | 2,658,066 | 0 | 0 | 0 | For |
| John Hancock | 2,247,454 | 0 | 0 | 0 | For |
| Invesco | 1,458,667 | 0 | 0 | 0 | For |
| Victory Capital | 1,337,197 | 0 | 0 | 0 | For |
| State Street | 1,254,570 | 0 | 0 | 0 | For |
| Dimensional | 935,911 | 0 | 0 | 0 | For |
| Charles Schwab | 738,419 | 0 | 0 | 0 | For |
| GMO | 568,962 | 0 | 0 | 0 | For |
| American Century | 567,125 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 429,772 | 0 | 0 | 0 | For |
| TIAA | 377,914 | 0 | 0 | 0 | For |
| DAVIS NEW YORK VENTURE FUND INC | 364,350 | 0 | 0 | 0 | For |
| Principal | 330,378 | 0 | 0 | 0 | For |
| First Trust | 316,610 | 0 | 0 | 0 | For |
| DAVIS SERIES INC | 276,843 | 0 | 0 | 0 | For |
| Jackson National | 254,082 | 0 | 0 | 0 | For |
| Goldman Sachs | 207,232 | 0 | 0 | 0 | For |
| FMI FUNDS INC | 190,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 185,672 | 0 | 0 | 0 | For |
| GMO ETF Trust | 176,930 | 0 | 0 | 0 | For |
Showing the 25 largest of 172 asset managers. See all 172 in the interactive database.
Meeting held 2026-05-20.
Combines 9 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Wright L. Lassiter, III”): 93,802,306 for, 223,154 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 110,696,429 outstanding shares: 85% for, 0.3% against (85% of the company cast a for/against vote).
The 172 asset managers below cast 99.9% of the shares they voted on this item FOR (42,495,530 for, 2,885 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,286,681 | 4 | 0 | 0 | For |
| BlackRock | 3,527,385 | 0 | 0 | 0 | For |
| Fidelity | 3,397,386 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,298,943 | 0 | 0 | 0 | For |
| JPMorgan | 2,658,066 | 0 | 0 | 0 | For |
| John Hancock | 2,247,454 | 0 | 0 | 0 | For |
| Invesco | 1,458,667 | 0 | 0 | 0 | For |
| Victory Capital | 1,337,197 | 0 | 0 | 0 | For |
| State Street | 1,254,570 | 0 | 0 | 0 | For |
| Dimensional | 935,911 | 0 | 0 | 0 | For |
| Charles Schwab | 738,419 | 0 | 0 | 0 | For |
| GMO | 568,962 | 0 | 0 | 0 | For |
| American Century | 567,125 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 429,772 | 0 | 0 | 0 | For |
| TIAA | 377,914 | 0 | 0 | 0 | For |
| DAVIS NEW YORK VENTURE FUND INC | 364,350 | 0 | 0 | 0 | For |
| Principal | 330,378 | 0 | 0 | 0 | For |
| First Trust | 316,610 | 0 | 0 | 0 | For |
| DAVIS SERIES INC | 276,843 | 0 | 0 | 0 | For |
| Jackson National | 254,082 | 0 | 0 | 0 | For |
| Goldman Sachs | 207,232 | 0 | 0 | 0 | For |
| FMI FUNDS INC | 190,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 185,672 | 0 | 0 | 0 | For |
| GMO ETF Trust | 176,930 | 0 | 0 | 0 | For |
Showing the 25 largest of 172 asset managers. See all 172 in the interactive database.
Meeting held 2026-05-20.
Combines 8 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Luis A. Diaz, Jr., M.D.”): 93,909,369 for, 110,114 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 110,696,429 outstanding shares: 85% for, 0.1% against (85% of the company cast a for/against vote).
The 171 asset managers below cast 99.9% of the shares they voted on this item FOR (42,495,531 for, 2,882 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,286,682 | 1 | 2 | 0 | For |
| BlackRock | 3,527,385 | 0 | 0 | 0 | For |
| Fidelity | 3,397,386 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,298,943 | 0 | 0 | 0 | For |
| JPMorgan | 2,658,066 | 0 | 0 | 0 | For |
| John Hancock | 2,247,454 | 0 | 0 | 0 | For |
| Invesco | 1,458,667 | 0 | 0 | 0 | For |
| Victory Capital | 1,337,197 | 0 | 0 | 0 | For |
| State Street | 1,254,570 | 0 | 0 | 0 | For |
| Dimensional | 935,911 | 0 | 0 | 0 | For |
| Charles Schwab | 738,419 | 0 | 0 | 0 | For |
| GMO | 568,962 | 0 | 0 | 0 | For |
| American Century | 567,125 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 429,772 | 0 | 0 | 0 | For |
| TIAA | 377,914 | 0 | 0 | 0 | For |
| DAVIS NEW YORK VENTURE FUND INC | 364,350 | 0 | 0 | 0 | For |
| Principal | 330,378 | 0 | 0 | 0 | For |
| First Trust | 316,610 | 0 | 0 | 0 | For |
| DAVIS SERIES INC | 276,843 | 0 | 0 | 0 | For |
| Jackson National | 254,082 | 0 | 0 | 0 | For |
| Goldman Sachs | 207,232 | 0 | 0 | 0 | For |
| FMI FUNDS INC | 190,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 185,672 | 0 | 0 | 0 | For |
| GMO ETF Trust | 176,930 | 0 | 0 | 0 | For |
Showing the 25 largest of 171 asset managers. See all 171 in the interactive database.
Meeting held 2026-05-20.
Combines 7 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Robert B. Carter”): 93,821,069 for, 205,166 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 110,696,429 outstanding shares: 85% for, 0.2% against (85% of the company cast a for/against vote).
The 171 asset managers below cast 99.9% of the shares they voted on this item FOR (42,495,530 for, 2,884 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,286,681 | 3 | 0 | 0 | For |
| BlackRock | 3,527,385 | 0 | 0 | 0 | For |
| Fidelity | 3,397,386 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,298,943 | 0 | 0 | 0 | For |
| JPMorgan | 2,658,066 | 0 | 0 | 0 | For |
| John Hancock | 2,247,454 | 0 | 0 | 0 | For |
| Invesco | 1,458,667 | 0 | 0 | 0 | For |
| Victory Capital | 1,337,197 | 0 | 0 | 0 | For |
| State Street | 1,254,570 | 0 | 0 | 0 | For |
| Dimensional | 935,911 | 0 | 0 | 0 | For |
| Charles Schwab | 738,419 | 0 | 0 | 0 | For |
| GMO | 568,962 | 0 | 0 | 0 | For |
| American Century | 567,125 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 429,772 | 0 | 0 | 0 | For |
| TIAA | 377,914 | 0 | 0 | 0 | For |
| DAVIS NEW YORK VENTURE FUND INC | 364,350 | 0 | 0 | 0 | For |
| Principal | 330,378 | 0 | 0 | 0 | For |
| First Trust | 316,610 | 0 | 0 | 0 | For |
| DAVIS SERIES INC | 276,843 | 0 | 0 | 0 | For |
| Jackson National | 254,082 | 0 | 0 | 0 | For |
| Goldman Sachs | 207,232 | 0 | 0 | 0 | For |
| FMI FUNDS INC | 190,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 185,672 | 0 | 0 | 0 | For |
| GMO ETF Trust | 176,930 | 0 | 0 | 0 | For |
Showing the 25 largest of 171 asset managers. See all 171 in the interactive database.
Meeting held 2026-05-20.
Combines 7 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Timothy C. Wentworth”): 93,427,490 for, 597,095 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 110,696,429 outstanding shares: 84% for, 0.6% against (85% of the company cast a for/against vote).
The 171 asset managers below cast 99.9% of the shares they voted on this item FOR (42,495,523 for, 2,892 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,286,674 | 11 | 2 | 0 | For |
| BlackRock | 3,527,385 | 0 | 0 | 0 | For |
| Fidelity | 3,397,386 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,298,943 | 0 | 0 | 0 | For |
| JPMorgan | 2,658,066 | 0 | 0 | 0 | For |
| John Hancock | 2,247,454 | 0 | 0 | 0 | For |
| Invesco | 1,458,667 | 0 | 0 | 0 | For |
| Victory Capital | 1,337,197 | 0 | 0 | 0 | For |
| State Street | 1,254,570 | 0 | 0 | 0 | For |
| Dimensional | 935,911 | 0 | 0 | 0 | For |
| Charles Schwab | 738,419 | 0 | 0 | 0 | For |
| GMO | 568,962 | 0 | 0 | 0 | For |
| American Century | 567,125 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 429,772 | 0 | 0 | 0 | For |
| TIAA | 377,914 | 0 | 0 | 0 | For |
| DAVIS NEW YORK VENTURE FUND INC | 364,350 | 0 | 0 | 0 | For |
| Principal | 330,378 | 0 | 0 | 0 | For |
| First Trust | 316,610 | 0 | 0 | 0 | For |
| DAVIS SERIES INC | 276,843 | 0 | 0 | 0 | For |
| Jackson National | 254,082 | 0 | 0 | 0 | For |
| Goldman Sachs | 207,232 | 0 | 0 | 0 | For |
| FMI FUNDS INC | 190,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 185,672 | 0 | 0 | 0 | For |
| GMO ETF Trust | 176,930 | 0 | 0 | 0 | For |
Showing the 25 largest of 171 asset managers. See all 171 in the interactive database.
Meeting held 2026-05-20.
Combines 7 wordings of this item as funds reported it.
89% Majority: yes · of votes cast
Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Vicky B. Gregg”): 83,814,387 for, 10,232,574 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 110,696,429 outstanding shares: 76% for, 9% against (85% of the company cast a for/against vote).
The 171 asset managers below cast 92% of the shares they voted on this item FOR (38,923,684 for, 3,574,729 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,286,496 | 188 | 1 | 0 | For |
| BlackRock | 3,527,385 | 0 | 0 | 0 | For |
| Fidelity | 3,354,695 | 42,691 | 0 | 0 | For |
| T. Rowe Price | 0 | 3,298,943 | 0 | 0 | Against |
| JPMorgan | 2,658,066 | 0 | 0 | 0 | For |
| John Hancock | 2,247,454 | 0 | 0 | 0 | For |
| Invesco | 1,458,667 | 0 | 0 | 0 | For |
| Victory Capital | 1,337,197 | 0 | 0 | 0 | For |
| State Street | 1,254,554 | 16 | 0 | 0 | For |
| Dimensional | 935,911 | 0 | 0 | 0 | For |
| Charles Schwab | 738,419 | 0 | 0 | 0 | For |
| GMO | 568,962 | 0 | 0 | 0 | For |
| American Century | 567,125 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 429,772 | 0 | 0 | 0 | For |
| TIAA | 377,914 | 0 | 0 | 0 | For |
| DAVIS NEW YORK VENTURE FUND INC | 364,350 | 0 | 0 | 0 | For |
| Principal | 330,378 | 0 | 0 | 0 | For |
| First Trust | 316,610 | 0 | 0 | 0 | For |
| DAVIS SERIES INC | 276,843 | 0 | 0 | 0 | For |
| Jackson National | 130,325 | 123,757 | 0 | 0 | For |
| Goldman Sachs | 207,232 | 0 | 0 | 0 | For |
| FMI FUNDS INC | 190,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 174,097 | 11,575 | 0 | 0 | For |
| GMO ETF Trust | 176,930 | 0 | 0 | 0 | For |
Showing the 25 largest of 171 asset managers. See all 171 in the interactive database.
Meeting held 2026-05-20.
Combines 6 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Quest Diagnostics Incorporated’s own tally for this item (“The ratification of the appointment of PricewaterhouseCoopers as the Company's independent registered public accounting firm for 2026 was approved by the following votes:”): 97,340,034 for, 5,809,995 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 110,696,429 outstanding shares: 88% for, 5% against (93% of the company cast a for/against vote).
The 170 asset managers below cast 99.5% of the shares they voted on this item FOR (42,189,552 for, 187,149 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,269,323 | 17,362 | 1 | 0 | For |
| BlackRock | 3,527,009 | 376 | 0 | 0 | For |
| Fidelity | 3,397,386 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,298,943 | 0 | 0 | 0 | For |
| JPMorgan | 2,658,066 | 0 | 0 | 0 | For |
| John Hancock | 2,247,454 | 0 | 0 | 0 | For |
| Invesco | 1,458,667 | 0 | 0 | 0 | For |
| Victory Capital | 1,337,197 | 0 | 0 | 0 | For |
| State Street | 1,254,554 | 16 | 0 | 0 | For |
| Dimensional | 935,911 | 0 | 0 | 0 | For |
| Charles Schwab | 738,419 | 0 | 0 | 0 | For |
| GMO | 568,962 | 0 | 0 | 0 | For |
| American Century | 567,125 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 429,772 | 0 | 0 | 0 | For |
| TIAA | 377,914 | 0 | 0 | 0 | For |
| DAVIS NEW YORK VENTURE FUND INC | 364,350 | 0 | 0 | 0 | For |
| Principal | 330,378 | 0 | 0 | 0 | For |
| First Trust | 316,610 | 0 | 0 | 0 | For |
| DAVIS SERIES INC | 276,843 | 0 | 0 | 0 | For |
| Jackson National | 254,082 | 0 | 0 | 0 | For |
| Goldman Sachs | 207,232 | 0 | 0 | 0 | For |
| FMI FUNDS INC | 190,000 | 0 | 0 | 0 | For |
| GMO ETF Trust | 176,930 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 175,078 | 0 | 0 | 0 | For |
Showing the 25 largest of 170 asset managers. See all 170 in the interactive database.
Meeting held 2026-05-20.
Combines 6 wordings of this item as funds reported it.
26% Majority: no · of votes cast
Quest Diagnostics Incorporated’s own tally for this item (“The stockholder proposal regarding an independent board chairman was not approved by the following votes:”): 23,999,636 for, 69,792,819 against, per its Form 8-K (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 110,696,429 outstanding shares: 22% for, 63% against (85% of the company cast a for/against vote).
The 170 asset managers below cast 13% of the shares they voted on this item FOR (5,362,985 for, 37,015,750 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 17,685 | 13,268,995 | 5 | 0 | Against |
| BlackRock | 1,817 | 3,525,568 | 0 | 0 | Against |
| Fidelity | 42,300 | 3,355,086 | 0 | 0 | Against |
| T. Rowe Price | 32,500 | 3,266,443 | 0 | 0 | Against |
| JPMorgan | 0 | 2,658,066 | 0 | 0 | Against |
| John Hancock | 2,123,202 | 124,252 | 0 | 0 | For |
| Invesco | 1,417,526 | 41,141 | 0 | 0 | For |
| Victory Capital | 0 | 1,337,197 | 0 | 0 | Against |
| State Street | 335 | 1,254,235 | 0 | 0 | Against |
| Dimensional | 0 | 935,911 | 0 | 0 | Against |
| Charles Schwab | 244 | 738,175 | 0 | 0 | Against |
| GMO | 0 | 568,962 | 0 | 0 | Against |
| American Century | 0 | 567,125 | 0 | 0 | Against |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 0 | 429,772 | 0 | 0 | Against |
| TIAA | 0 | 377,914 | 0 | 0 | Against |
| DAVIS NEW YORK VENTURE FUND INC | 0 | 364,350 | 0 | 0 | Against |
| Principal | 0 | 330,378 | 0 | 0 | Against |
| First Trust | 0 | 316,610 | 0 | 0 | Against |
| DAVIS SERIES INC | 0 | 276,843 | 0 | 0 | Against |
| Jackson National | 0 | 254,082 | 0 | 0 | Against |
| Goldman Sachs | 0 | 207,232 | 0 | 0 | Against |
| FMI FUNDS INC | 190,000 | 0 | 0 | 0 | For |
| GMO ETF Trust | 0 | 176,930 | 0 | 0 | Against |
| CARILLON SERIES TRUST | 0 | 175,078 | 0 | 0 | Against |
Showing the 25 largest of 170 asset managers. See all 170 in the interactive database.
Meeting held 2026-05-20.
92% Majority: yes · of votes cast
Quest Diagnostics Incorporated’s own tally for this item (“The advisory resolution to approve the executive officer compensation disclosed in the Company's 2026 Proxy Statement was approved by the following votes:”): 86,869,738 for, 7,152,448 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 110,696,429 outstanding shares: 78% for, 6% against (85% of the company cast a for/against vote).
The 31 asset managers below cast 47.6% of the shares they voted on this item FOR (475,499 for, 524,446 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| APG Asset Management US Inc. | 0 | 356,502 | 0 | 0 | Against |
| STOREBRAND ASSET MANAGEMENT AS | 140,469 | 0 | 0 | 0 | For |
| ANTIPODES PARTNERS Ltd | 76,397 | 0 | 0 | 0 | For |
| Empower | 66,533 | 0 | 0 | 0 | For |
| NORDEA INVESTMENT MANAGEMENT AB | 0 | 65,435 | 0 | 0 | Against |
| Cardano Risk Management B.V. | 0 | 61,693 | 0 | 0 | Against |
| Lincoln Financial | 43,542 | 0 | 0 | 0 | For |
| CSM Advisors, LLC | 42,372 | 0 | 0 | 0 | For |
| TD Waterhouse Canada Inc. | 37,240 | 0 | 0 | 0 | For |
| Swiss Life Asset Management Ltd | 0 | 32,486 | 0 | 0 | Against |
| Wilshire Advisors LLC | 24,899 | 0 | 0 | 0 | For |
| CAMBIAR INVESTORS LLC | 18,597 | 0 | 0 | 0 | For |
| Arjuna Capital | 0 | 8,313 | 0 | 0 | Against |
| AGF Investments Trust | 8,008 | 0 | 0 | 0 | For |
| Vinva Investment Management Ltd | 3,753 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 0 | 0 | 0 | Not Voted |
| NORTHERN LIGHTS FUND TRUST II | 2,400 | 0 | 0 | 0 | For |
| Metzler Asset Management GmbH | 1,967 | 0 | 0 | 0 | For |
| WASHINGTON CAPITAL MANAGEMENT, INC | 1,780 | 0 | 0 | 0 | For |
| Osmosis Investment Management UK Ltd | 1,753 | 0 | 0 | 0 | For |
| Douglass Winthrop Advisors, LLC | 1,750 | 0 | 0 | 0 | For |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma | 1,539 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 1,331 | 0 | 0 | 0 | For |
| Qtron Investments LLC | 753 | 0 | 0 | 0 | For |
| Westbourne Investment Advisors, Inc. | 200 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.
Meeting held 2026-05-20.
94% Majority: yes · of votes cast
Quest Diagnostics Incorporated’s own tally for this item (“The ratification of the appointment of PricewaterhouseCoopers as the Company's independent registered public accounting firm for 2026 was approved by the following votes:”): 97,340,034 for, 5,809,995 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 110,696,429 outstanding shares: 88% for, 5% against (93% of the company cast a for/against vote).
The 5 asset managers below cast 100% of the shares they voted on this item FOR (121,814 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Empower | 66,533 | 0 | 0 | 0 | For |
| Lincoln Financial | 43,542 | 0 | 0 | 0 | For |
| AGF Investments Trust | 8,008 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 2,400 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 1,331 | 0 | 0 | 0 | For |
Meeting held 2026-05-20.
9% fund support · no official result
The 5 asset managers below cast 9% of the shares they voted on this item FOR (10,408 for, 111,406 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Empower | 0 | 66,533 | 0 | 0 | Against |
| Lincoln Financial | 0 | 43,542 | 0 | 0 | Against |
| AGF Investments Trust | 8,008 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 2,400 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 1,331 | 0 | 0 | Against |
Meeting held 2025-05-15 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Quest Diagnostics Incorporated’s own tally for this item (“The advisory resolution to approve the executive officer compensation disclosed in the Company's 2025 Proxy Statement was approved by the following votes:”): 85,922,577 for, 8,570,674 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 110,696,429 outstanding shares: 78% for, 8% against (85% of the company cast a for/against vote).
The 3 asset managers below cast 89% of the shares they voted on this item FOR (5,765 for, 682 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Investment Management Corp of Ontario | 3,485 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 2,280 | 0 | 0 | 0 | For |
| OSSIAM | 0 | 682 | 0 | 0 | Against |
Reported under meeting date 2026-03-23; no official results on file for that date.
2% fund support · no official result
The 2 asset managers below cast 2% of the shares they voted on this item FOR (4,085 for, 215,892 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| SCHRODER INVESTMENT MANAGEMENT GROUP | 0 | 215,892 | 0 | 0 | Against |
| Soviero Asset Management, LP | 4,085 | 0 | 0 | 0 | For |
Ranked by the number of Quest Diagnostics Incorporated shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 110,696,429 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 13.05% |
| 2 | T. Rowe Price | 8.91% |
| 3 | BlackRock | 6.69% |
| 4 | Fidelity | 3.86% |
| 5 | Boston Partners | 3.15% |
| 6 | State Street | 3.07% |
| 7 | Victory Capital | 2.80% |
| 8 | Invesco | 2.78% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 2.78% |
| 10 | JPMorgan | 2.40% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Vanguard Group | 13.00% | 13F |
| BlackRock, Inc. | 8.41% | DEF14A |
| T. Rowe Price Associates, Inc. | 4.90% | 13G |
| State Street | 4.86% | 13F |
| JPMorgan Chase | 3.47% | 13F |
| Geode Capital | 2.79% | 13F |
| Morgan Stanley | 2.43% | 13F |
| Dimensional Fund Advisors | 1.76% | 13F |
| Invesco | 1.48% | 13F |
| Goldman Sachs | 1.22% | 13F |
Percentages above are of 110,696,429 shares outstanding, as reported by Quest Diagnostics Incorporated on its Form 10-Q dated 2026-04-15 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Quest Diagnostics Incorporated’s 10-Q dated 2026-04-15. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At Quest Diagnostics Incorporated's shareholder meeting held 2026-05-20, in the 2025-2026 proxy season, 926 asset managers reported how they voted in their SEC Form N-PX filings, covering 12,615 separate fund positions. Their filings are grouped here into 19 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — An advisory resolution to approve the executive officer compensation disclosed in the Company's… — FOR was 92% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Quest Diagnostics Incorporated's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission (filing date not recorded for this item).
Quest Diagnostics Incorporated proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).